Khan, H.; Gallant, R.C.; Zamzam, A.; Jain, S.; Afxentiou, S.; Syed, M.; Kroezen, Z.; Shanmuganathan, M.; Britz-McKibbin, P.; Rand, M.L.;
et al. Personalization of Aspirin Therapy Ex Vivo in Patients with Atherosclerosis Using Light Transmission Aggregometry. Diagnostics 2020, 10, 871.
https://doi.org/10.3390/diagnostics10110871
AMA Style
Khan H, Gallant RC, Zamzam A, Jain S, Afxentiou S, Syed M, Kroezen Z, Shanmuganathan M, Britz-McKibbin P, Rand ML,
et al. Personalization of Aspirin Therapy Ex Vivo in Patients with Atherosclerosis Using Light Transmission Aggregometry. Diagnostics. 2020; 10(11):871.
https://doi.org/10.3390/diagnostics10110871
Chicago/Turabian Style
Khan, Hamzah, Reid C. Gallant, Abdelrahman Zamzam, Shubha Jain, Sherri Afxentiou, Muzammil Syed, Zachary Kroezen, Meera Shanmuganathan, Philip Britz-McKibbin, Margaret L. Rand,
and et al. 2020. "Personalization of Aspirin Therapy Ex Vivo in Patients with Atherosclerosis Using Light Transmission Aggregometry" Diagnostics 10, no. 11: 871.
https://doi.org/10.3390/diagnostics10110871
APA Style
Khan, H., Gallant, R. C., Zamzam, A., Jain, S., Afxentiou, S., Syed, M., Kroezen, Z., Shanmuganathan, M., Britz-McKibbin, P., Rand, M. L., Ni, H., Al-Omran, M., & Qadura, M.
(2020). Personalization of Aspirin Therapy Ex Vivo in Patients with Atherosclerosis Using Light Transmission Aggregometry. Diagnostics, 10(11), 871.
https://doi.org/10.3390/diagnostics10110871
